Breakthrough in Cancer Gene Therapy: Researchers Develop Efficient DNA Delivery Carrier

Strategic Insights -

Researchers at Ezhou Central Hospital have made significant progress in cancer gene therapy, developing a novel DNA delivery carrier that combines photothermal therapy with gene therapy to target cancer cells. This innovative approach has shown promise in treating cancer and has been peer-reviewed in the journal Bioorganic Chemistry. The researchers have utilized a facile chemical grafting strategy to construct a combination of photothermal and gene therapy nanocarrier system through amide reaction, resulting in a carrier that exhibits superior dispersibility and transfection efficiency.

Key Takeaways:

  • The researchers have developed a novel DNA delivery carrier that combines photothermal therapy with gene therapy to target cancer cells.
  • The carrier was constructed through a facile chemical grafting strategy, resulting in a combination of photothermal and gene therapy nanocarrier system.
  • The carrier exhibits superior dispersibility and transfection efficiency, with transfection efficiencies of 47.44% and 54.56% in HeLa cells.
  • The carrier has shown promise in treating cancer, with survival rates of HepG2 and MCF-7 cells below 10% at a carrier concentration of 40 mg/mL.
  • The research has laid the foundation for the development of low-toxicity and high-efficiency gene delivery carriers.
  • The researchers have utilized carbon nanotubes (CNTs) functionalized with polyethyleneimine (PEI) to enhance the dispersibility and transfection efficiency of the carrier.
  • The carrier has been tested in vitro experiments, showing strong photothermal effects when exposed to 808 nm near-infrared light.

Statistics:

  • The carrier exhibits transfection efficiencies of 47.44% and 54.56% in HeLa cells.
  • The survival rates of HepG2 and MCF-7 cells were below 10% at a carrier concentration of 40 mg/mL.
  • The carrier was constructed in a facile chemical grafting strategy through amide reaction.
  • The transfection efficiencies of CNTs-PEI10k/DNA and CNTs-PEI25k/DNA were 47.44% and 54.56%, respectively.

Sources:

  • Ezhou Central Hospital Reports Findings in Cancer Gene Therapy (Integration of polyethylenimine functionalized carbon nanotubes nanocarriers for efficient DNA delivery). Nanotechnology Weekly. July 7, 2025; p 925.
  • Integration of polyethylenimine functionalized carbon nanotubes nanocarriers for efficient DNA delivery. Bioorganic Chemistry, 2025;163:108701.
  • Elsevier Science, 525 B St, Ste 1900, San Diego, CA 92101-4495, USA. (Elsevier - www.elsevier.com; Bioorganic Chemistry - www.journals.elsevier.com/bioorganic-chemistry/)